Prophylactic effects of the histamine H 1 receptor antagonist epinastine and the dual thromboxane A 2 receptor and chemoattractant receptor-homologous molecule expressed on Th2 cells antagonist ramatroban on allergic rhinitis model in mice

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 4, 2011, Pages 507-510

  Suzuki, Yuh ^a   Inoue, Toshio ^b   Yamamoto, Atsuki ^a   Sugimoto, Yukio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Eosinophil; Epinastine; Histamine H 1 receptor; Ramatroban; Rhinitis; Thromboxane A 2 receptor

Indexed keywords

CHEMOATTRACTANT; EPINASTINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; RAMATROBAN; SERATRODAST; THROMBOXANE A2 RECEPTOR;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; FEMALE; MOUSE; NASAL RUBBING; NONHUMAN; NOSE ALLERGY; NOSE MUCOSA; PROPHYLAXIS; SNEEZING; SYMPTOM;

ANIMALS; ANTI-ALLERGIC AGENTS; BEHAVIOR, ANIMAL; BENZOQUINONES; CARBAZOLES; DIBENZAZEPINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HEPTANOIC ACIDS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; IMIDAZOLES; MICE; MICE, INBRED BALB C; NASAL MUCOSA; PROSTAGLANDIN ANTAGONISTS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; SNEEZING; SULFONAMIDES; TH2 CELLS;

EID: 79953775177     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.507     Document Type: Article

References (41)

1. Kishi K., Saito M., Saito T., Kumemura M., Okamatsu H., Okita M., Takazawa K., Biosci. Biotechnol. Biochem., 69, 829-832 (2005).
2. Gelfand E. W., J. Allergy Clin. Immunol., 114, S135-S138 (2004).
3. Tai C. F., Baraniuk J. N., Curr. Opin. Allergy Clin. Immunol., 2, 11-19 (2002).
4. Howarth P. H., Salagean M., Dokic D., Allergy, 55, 7-16 (2000).
5. Sarin S., Undem B., Sanico A., Togias A., J. Allergy Clin. Immunol., 118, 999-1016 (2006).
6. Shirasaki H., Kikuchi M., Seki N., Kanaizumi E., Watanabe K., Himi T., Prostaglandins Leukot. Essent. Fatty Acids, 76, 315-320 (2007).
7. Nakanishi Y., Nabe T., Mizutani N., Takenaka H., Kohno S., Prostaglandins Other Lipid Mediat., 74, 125-137 (2004).
8. Yamasaki M., Mizutani N., Sasaki K., Nabe T., Matsumoto T., Ashida Y., Kohno S., Inflamm. Res., 50, 466-473 (2001).
9. Settipane R. A., Charnock D. R., Clin. Allergy Immunol., 19, 23-34 (2007).
10. Okubo K., Gotoh M., Shimada K., Ritsu M., Okuda M., Crawford B., Int. Arch. Allergy Immunol., 136, 148-154 (2005).
11. Kurowski M., Kuna P., Górski P., Allergy, 59, 280-288 (2004).
12. Pitsios C., Papadopoulos D., Kompoti E., Manoussakis E., Garris V., Petalas K., Tassios I., Baibas N., Kontou-Fili K., Saxoni-Papageorgiou P., Papadopoulos N. G., Ann. Allergy Asthma Immunol., 96, 673-678 (2006).
13. Kayasuga R., Sugimoto Y., Watanabe T., Kamei C., Eur. J. Pharmacol., 449, 287-291 (2002).
14. Miyagawa N., Iwasaki H., Kato T., Tanaka M., Shibata T., Wakitani K., Biol. Pharm. Bull., 31, 2260-2264 (2008).
15. Yamasaki M., Sasaki K., Mizutani N., Nabe T., Sakura Y., Matsumoto T., Ashida Y., Kohno S., Inflamm. Res., 50, 474-482 (2001).
16. Kishi Y., Nakano Y., Jiang S., Yatsuzuka R., Kamei C., Int. Immunopharmacol., 7, 1483-1487 (2007).
17. Johnston S. L., Smith S., Harrison J., Ritter W., Howarth P. H., J. Allergy Clin. Immunol., 91, 903-909 (1993).
18. Yamasaki M., Matsumoto T., Fukuda S., Nakayama T., Nagaya H., Ashida Y., J. Pharmacol. Exp. Ther., 280, 1471-1479 (1997).
19. Narita S., Asakura K., Kataura A., Int. Arch. Allergy Immunol., 109, 161-166 (1996).
20. Kayasuga R., Iba Y., Hossen M. A., Watanabe T., Kamei C., Int. Immunopharmacol., 3, 469-473 (2003).
21. Tanaka K., Ogawa K., Sugamura K., Nakamura M., Takano S., Nagata K., J. Immunol., 164, 2277-2280 (2000).
22. Hirai H., Tanaka K., Yoshie O., Ogawa K., Kenmotsu K., Takamori Y., Ichimasa M., Sugamura K., Nakamura M., Takano S., Nagata K., J. Exp. Med., 193, 255-261 (2001).
23. Pettipher R., Br. J. Pharmacol., 153, S191-S199 (2008).
24. Rahman A., Inoue T., Ago J., Ishikawa T., Kamei C., Eur. J. Pharmacol., 554, 229-234 (2007).
25. Mizuguchi H., Hatano M., Matsushita C., Umehara H., Kuroda W., Kitamura Y., Takeda N., Fukui H., J. Pharmacol. Sci., 108, 480-486 (2008).
26. Fukui H., J. Pharmacol. Sci., 106, 325-331 (2008).
27. Kanthawatana S., Maturim W., Fooanant S., Manorot M., Trakultivakorn M., Asian Pac. J. Allergy Immunol., 15, 65-69 (1997).
28. Mizutani N., Nabe T., Takenaka H., Kohno S., J. Pharmacol. Sci., 93, 437-445 (2003).
29. Jankowski R., Persoons M., Foliguet B., Coffinet L., Thomas C., Verient- Montaut B., Rhinology, 38, 23-32 (2000).
30. Gleich G. J., Loegering D. A., Ann. Rev. Immunol., 2, 429-459 (1984).
31. Gleich G. J., J. Allergy Clin. Immunol., 105, 651-663 (2000).
32. Baraniuk J. N., J. Allergy Clin. Immunol., 99, S763-S772 (1997).
33. Kamei C., Mio M., Kitazumi K., Tsujimoto S., Yoshida T., Adachi Y., Tasaka K., Immunopharmacol. Immunotoxicol., 14, 207-218 (1992).
34. Matsukura M., Yajima A., Yamazaki F., Yudate T., Yamada H., Tezuka T., Skin Pharmacol. Appl. Skin Physiol., 16, 405-410 (2003).
35. Mitsuhashi M., Tanaka A., Fujisawa C., Kawamoto K., Itakura A., Takaku M., Hironaka T., Sawada S., Matsuda H., J. Immunol., 166, 617-623 (2001).
36. Sugimoto H., Shichijo M., Iino T., Manabe Y., Watanabe A., Shimazaki M., Gantner F., Bacon K. B., J. Pharmacol. Exp. Ther., 305, 347-352 (2003).
37. Shichijo M., Sugimoto H., Nagao K., Inbe H., Encinas J. A., Takeshita K., Bacon K. B., Gantner F., J. Pharmacol. Exp. Ther., 307, 518-525 (2003).
38. de Graaf-in 't Veld C., Garrelds I. M., Koenders S., Gerth van Wijk R., Clin. Exp. Allergy, 26, 903-908 (1996).
39. Terada N., Yamakoshi, T., Hasegawa, M., Tanikawa, H., Nagata H., Maesako K., Konno A., Allergol. Int., 47, 59-67 (1998).
40. Murata Y., Miyoshi A., Kitamura Y., Takeda N., Fukui H., Inflamm. Res., 53 (Suppl. 1), S11-S12 (2004).
41. Ohkawa C., Ukai K., Miyahara Y., Takeuchi K., Sakakura Y., Auris. Nasus. Larynx., 26, 293-298 (1999).